Aristotle University Of Thessaloniki (AUTH)
Αξιολόγηση της έκφρασης βιολογικών δεικτών σε ασθενείς με επιφανειακό καρκίνο της ουροδόχου κύστης υπό συμπληρωματική ενδοκυστική θεραπεία
Abstract
dc:descriptionThis study investigates whether the use of intravesical treatment regimes affects biomarkers CD10, Her2, Ki67, p53, E-cadherin, B-catenin in superficial bladder cancer. The 6 tumour markers were studied in the biopsy material of the 1st TUR-BT and 2nd TUR-BT respectively. All of these studies were performed using immunohistochemical methods in order to identify a prognostic group including certain of the above-mentioned markers. The studied group consists of 24 patients with superficial bladder cancer (pTa, pT1) from the Theagenio Cancer Hospital of Thessaloniki, who underwent first-time transurethral resection of bladder tumour - 1st TUR-BT (starting point 0). At point 1, the same patients were studied upon first relapse, after being treated with intravesical formulations and undergoing a 2nd TUR-BT. The 24 patients are classified based on the use of the intravesical therapeutic formulations: 8 of them received supplementary therapy with BCG, 8 with Mitomycin and 8 with Epirubicin, respectively. The changes occurring in the expression of the same molecular markers following the administration of intravesical regimens were thus noted, aiming to evaluate their efficacy at the molecular level, as well as the possibility of designing new formulations based on the conclusions drawn. Our study showed that, after treatment, there was a decrease in the expression of CD10 and p53, and an increase of HER2. For markers Ki67, E-cadherin and B-catenin, post-treatment results were mixed. No statistically significant change in post-treatment expression was observed for any of the markers. The role of the HER2 marker in patient survival is negative, as compared to CD10, p53, ki67, E-cadherin, Β-catenin. Cas-es with positive HER2 expression did not appear to have benefited from treatment (as HER2 expression increased after treatment). Perhaps more appropriate therapeutic regimes should be designed in the future. Cases in which the post-treatment expression of markers CD10 and p53 decreased probably benefited from the treatment. The statistical analysis revealed results concerning secondary parameters of the study, as detailed in our conclusions.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Moustakas, Georgios
- Μουστάκας, Γεώργιος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47399